Skip to main
DCGO

DocGo (DCGO) Stock Forecast & Price Target

DocGo (DCGO) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

DocGo is poised for significant growth in the near and long term, with impressive y/y and q/q growth in key segments such as transportation, healthcare in the home, and remote patient monitoring. The company has also successfully expanded its national payer relationships and showed potential for profitable operations with its RPM segment achieving a gross margin of over 50%. Additionally, steady growth projections and a strong cash balance make DocGo an attractive investment opportunity.

Bears say

DocGo is facing significant challenges in growing revenue and cutting costs, with a primary reliance on migrant services to drive topline growth. Additionally, their mobile health business, which includes virtual care and other on-site services, is declining organically. Despite strong volumes in core transportation, the company still has a long way to go to rightsize its cost structure and achieve profitability. There may be potential for a positive outcome from the strategic review, but significant risks such as government regulation and competition should be considered.

DocGo (DCGO) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of DocGo and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About DocGo (DCGO) Forecast

Analysts have given DocGo (DCGO) a Buy based on their latest research and market trends.

According to 4 analysts, DocGo (DCGO) has a Buy consensus rating as of May 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $2.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $2.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

DocGo (DCGO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.